{"pmid":32299844,"title":"COVID-19 and rheumatology: first steps towards a different future?","text":["COVID-19 and rheumatology: first steps towards a different future?","Ann Rheum Dis","McInnes, Iain B","32299844"],"journal":"Ann Rheum Dis","authors":["McInnes, Iain B"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32299844","week":"202016|Apr 13 - Apr 19","doi":"10.1136/annrheumdis-2020-217494","keywords":["arthritis, rheumatoid","rehabilitation","rheumatoid factor"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664357978554236928,"score":8.233237,"similar":[{"pmid":32241793,"title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.","text":["Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.","Ann Rheum Dis","Monti, Sara","Balduzzi, Silvia","Delvino, Paolo","Bellis, Elisa","Quadrelli, Verdiana Serena","Montecucco, Carlomaurizio","32241793"],"journal":"Ann Rheum Dis","authors":["Monti, Sara","Balduzzi, Silvia","Delvino, Paolo","Bellis, Elisa","Quadrelli, Verdiana Serena","Montecucco, Carlomaurizio"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241793","week":"202014|Mar 30 - Apr 05","doi":"10.1136/annrheumdis-2020-217424","keywords":["antirheumatic agents","arthritis, rheumatoid","biological therapy","spondylitis, ankylosing"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352135795867648,"score":64.83339},{"pmid":32297458,"title":"How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","text":["How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved.","PM R","Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K","32297458"],"abstract":["The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved."],"journal":"PM R","authors":["Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297458","week":"202016|Apr 13 - Apr 19","doi":"10.1002/pmrj.12380","keywords":["Telemedicine","rehabilitation","telehealth","virtual visit"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266651319664640,"score":64.521576},{"pmid":32292884,"pmcid":"PMC7140724","title":"Important Steps to Control COVID-19/SARS-CoV-2 Infection.","text":["Important Steps to Control COVID-19/SARS-CoV-2 Infection.","Elderly patients are having high mortality rates from COVID-19/SARS-CoV-2 infection compared to younger patients. The SARS-CoV-2 virus uses the ACE2 receptor as the entry point to the host cells. ARBs/ACEIs which are widely used in elderly patients, have been found to be associated with overexpression of ACE2.To decrease the severity of COVID-19 infection, ARB/ACEI should be switched to another class drug not known to cause a rise in ACE2 until the COVID-19 infection subsides. Specific human immunoglobulin can be tried for COVID-19 patients with critical conditions under supervision.","SN Compr Clin Med","Chatterjee, Sudipto","32292884"],"abstract":["Elderly patients are having high mortality rates from COVID-19/SARS-CoV-2 infection compared to younger patients. The SARS-CoV-2 virus uses the ACE2 receptor as the entry point to the host cells. ARBs/ACEIs which are widely used in elderly patients, have been found to be associated with overexpression of ACE2.To decrease the severity of COVID-19 infection, ARB/ACEI should be switched to another class drug not known to cause a rise in ACE2 until the COVID-19 infection subsides. Specific human immunoglobulin can be tried for COVID-19 patients with critical conditions under supervision."],"journal":"SN Compr Clin Med","authors":["Chatterjee, Sudipto"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292884","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s42399-020-00271-7","keywords":["ACE2","ACEI","ARB","COVID-19","SARS-CoV-2"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1664266295594450944,"score":59.426373},{"pmid":32171067,"pmcid":"PMC7103991","title":"Sex difference and smoking predisposition in patients with COVID-19.","text":["Sex difference and smoking predisposition in patients with COVID-19.","Lancet Respir Med","Cai, Hua","32171067"],"journal":"Lancet Respir Med","authors":["Cai, Hua"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32171067","week":"202011|Mar 09 - Mar 15","doi":"10.1016/S2213-2600(20)30117-X","link_erratum_in":"32246931","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663352133960859650,"score":46.91012},{"pmid":32272857,"title":"The Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks.","text":["The Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks.","In light of the current novel coronavirus (COVID-19) pandemic as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well-suited to apply their skillset to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines and tissue engineers are well-trained to be leaders and contributors in this time of need.","Tissue Eng Part A","Tatara, Alexander M","32272857"],"abstract":["In light of the current novel coronavirus (COVID-19) pandemic as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well-suited to apply their skillset to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines and tissue engineers are well-trained to be leaders and contributors in this time of need."],"journal":"Tissue Eng Part A","authors":["Tatara, Alexander M"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32272857","week":"202015|Apr 06 - Apr 12","doi":"10.1089/ten.TEA.2020.0094","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1663712077943930880,"score":45.38244}]}